Get started
Author

Mary Katherine Cheeley

Observed names: Mary Cheeley, Mary K. Cheeley
Institution: Grady Health System
ORCID: 0009-0001-9230-4276
Observed ORCID: 0009-0001-9230-4276
OpenAlex ID: A5024130231
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
2022 · Mary Katherine Cheeley, Joseph J. Saseen, et al. · Journal of clinical lipidology · 206
The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy
2019 · Terry A. Jacobson, Mary Katherine Cheeley, et al. · Journal of clinical lipidology · 62
Statin Intolerance: an Overview of US and International Guidance
2023 · Mary Katherine Cheeley, Katarina Clegg, et al. · Current Atherosclerosis Reports · 18
PDF
Statin-Associated Muscle Symptoms: Identification and Recommendations for Management
2024 · Kevin C. Maki, Carol F. Kirkpatrick, et al. · Current Atherosclerosis Reports · 11
Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review
2025 · Mary Katherine Cheeley, Carol F. Kirkpatrick, et al. · Journal of clinical lipidology · 4
Lipidology: The time is now for specialty recognition
2024 · Kaye-Eileen Willard, Don P. Wilson, et al. · Journal of clinical lipidology · 2
PDF
Community pharmacist impact of addressing statin use in patients with diabetes
2025 · Salman Hasham, Mary Cheeley, et al. · Journal of clinical lipidology · 1
Lp(a) Ordering Patterns and Insights from a Large County Teaching Hospital System
2026 · Michael Kimbrell, Terry Jacobson, et al. · Journal of clinical lipidology
Unmet needs for lipid management in patients with peripheral arterial disease: A narrative review
2026 · Demetria M. Bolden, Mary Katherine Cheeley, et al. · Journal of clinical lipidology
Impact of PCSK9 monoclonal antibody inhibitors on Lp(a) reduction in African Americans with elevated Lp(a)
2025 · Cindy Nee, Mary Katherine Cheeley, et al. · Journal of clinical lipidology
Abstract 4144868: Optimizing the Care of Patients with Cardiac Amyloidosis in a Safety Net Hospital: A Multidisciplinary Heart Team Approach
2024 · Joshua Stephens, Oreoluwa Olakunle, et al. · Circulation
Optimizing Residual Cardiovascular Risk in a Case of Homozygous Familial Hypercholesterolemia (HoFH) and Elevated Lipoprotein (a) [Lp(a)]
2024 · Salman Hasham, Mary Cheeley, et al. · Journal of clinical lipidology
A Case Report of Familial Hypercholesterolemia With Unprecedented Response to Plasmapheresis
2024 · Samed Obeng, Anthony Lyonga Ngonge, et al. · Journal of the American College of Cardiology
Pharmaceutical Development and Approval in the United States of Agents to Influence Cardiovascular Health
2024 · Mary Katherine Cheeley, Laurie Cavendish · Contemporary cardiology
Coronary Artery Calcium scores in asymptomatic minority subjects with phenotypic Familial Hypercholesterolemia*
2019 · Allison M. Hester, Mary Katherine Cheeley, et al. · Journal of clinical lipidology
Familial Hypercholesterolemia GENEtic evaluation of Minority patients with an LDL-C >190mg/dL: FH GENE-Minority Study
2019 · Mary Katherine Cheeley, Allison Hester, et al. · Journal of clinical lipidology
Evaluation of Statin Prescribing in Patients With an LDL ≥ 190 mg/dL in an Inner City Teaching Hospital
2017 · Julianne Jones, Mary Cheeley, et al. · Journal of clinical lipidology
Incidence of Statin Intolerance in a Referral Lipid Clinic: Patient Characteristics and Response to Rechallenge*
2015 · Mary K. Cheeley, Clara Ni, et al. · Journal of clinical lipidology
PDF
Works count: 18
Citation count: 304
H-index: 4
I10-index: 4
Year
Topic
Type